These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7681916

  • 41. Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.
    Iwamoto T, Nishimura N, Morita T, Sukamoto T.
    J Pharm Pharmacol; 1993 Apr; 45(4):292-7. PubMed ID: 8098370
    [Abstract] [Full Text] [Related]

  • 42. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
    Minkes RK, Kvamme P, Higuera TR, Nossaman BD, Kadowitz PJ.
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
    [Abstract] [Full Text] [Related]

  • 43. Effects of intracoronary glyburide on cesium-induced arrhythmias in anesthetized dogs.
    D'Alonzo AJ, Hess TA, Darbenzio RB, Sewter JC.
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):446-52. PubMed ID: 7515989
    [Abstract] [Full Text] [Related]

  • 44. Dilating effect of perivascularly applied potassium channel openers cromakalim and pinacidil in rat and cat pial arteries in situ.
    Wahl M, Parsons AA, Schilling L.
    Cardiovasc Res; 1994 Dec; 28(12):1803-7. PubMed ID: 7867033
    [Abstract] [Full Text] [Related]

  • 45. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
    Triggle CR, Li YQ, Wyse DG.
    Proc West Pharmacol Soc; 1992 Dec; 35():97-102. PubMed ID: 1502246
    [No Abstract] [Full Text] [Related]

  • 46. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
    Longman SD, Clapham JC, Wilson C, Hamilton TC.
    J Cardiovasc Pharmacol; 1988 Dec; 12(5):535-42. PubMed ID: 2468052
    [Abstract] [Full Text] [Related]

  • 47. Cromakalim and pinacidil dilate small mesenteric arteries but not small cerebral arteries.
    McCarron JG, Quayle JM, Halpern W, Nelson MT.
    Am J Physiol; 1991 Aug; 261(2 Pt 2):H287-91. PubMed ID: 1908639
    [Abstract] [Full Text] [Related]

  • 48. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA, Angus JA.
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Effects of cromakalim (BRL 34915) and pinacidil on normal and hypertrophied rat detrusor in vitro.
    Malmgren A, Andersson KE, Andersson PO, Fovaeus M, Sjögren C.
    J Urol; 1990 Apr; 143(4):828-34. PubMed ID: 2313820
    [Abstract] [Full Text] [Related]

  • 51. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
    Imagawa J, Akima M, Nabata H, Taira N.
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676
    [Abstract] [Full Text] [Related]

  • 52. Cromakalim does not protect against skeletal muscle fatigue in an anaesthetized rat model of acute hindlimb ischaemia.
    Trezise DJ, Drew GM, Roach AG, Watts IS, Weston AH.
    Eur J Pharmacol; 1993 Nov 30; 250(1):109-16. PubMed ID: 8119308
    [Abstract] [Full Text] [Related]

  • 53. Suppression of ventricular arrhythmias after coronary artery ligation by pinacidil, a vasodilator drug.
    Kerr MJ, Wilson R, Shanks RG.
    J Cardiovasc Pharmacol; 1985 Nov 30; 7(5):875-83. PubMed ID: 2413295
    [Abstract] [Full Text] [Related]

  • 54. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H, Yoneyama F, Satoh K, Taira N.
    Br J Pharmacol; 1990 Jul 30; 100(3):413-6. PubMed ID: 2143956
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
    Kamijo T, Iwai T, Haruta K, Takeda K.
    Arch Int Pharmacodyn Ther; 1996 Jul 30; 331(3):273-84. PubMed ID: 9124999
    [Abstract] [Full Text] [Related]

  • 57. K(+)-channel openers for relaxation of isolated penile erectile tissue from rabbit.
    Holmquist F, Andersson KE, Fovaeus M, Hedlund H.
    J Urol; 1990 Jul 30; 144(1):146-51. PubMed ID: 2359166
    [Abstract] [Full Text] [Related]

  • 58. Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs.
    Grover GJ, Sleph PG, Dzwonczyk S.
    J Cardiovasc Pharmacol; 1990 Dec 30; 16(6):853-64. PubMed ID: 1704976
    [Abstract] [Full Text] [Related]

  • 59. Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
    Rees SA, Tsuchihashi K, Hearse DJ, Curtis MJ.
    J Cardiovasc Pharmacol; 1993 Sep 30; 22(3):343-9. PubMed ID: 7504122
    [Abstract] [Full Text] [Related]

  • 60. Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil.
    Randall MD, Griffith TM.
    Br J Pharmacol; 1993 Jun 30; 109(2):386-93. PubMed ID: 8358541
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.